The US government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed programme
Sanofi plans to further investigate an advanced pre-clinical SARS vaccine candidate that could protect against COVID-19
Sanofi had acquired Shantha Biotechnics in 2009, which makes vaccines for the company in India